Loading…
the sparker alert will let you know when a significant move starts with an audio alert, so You'll never miss an Opportunity.
Enveric Biosciences Inc Is A Biotechnology Company Dedicated To The Development Of Novel Neuroplastogenic Small-Molecule Therapeutics For The Treatment Of Depression, Anxiety, Addiction, And Other Psychiatric Disorders. The Company'S Program, Eb-003, Is A First-In-Class Approach To The Treatment Of Difficult-To-Address Mental Health Disorders Designed To Promote Neuroplasticity Without Inducing Hallucinations In The Patient. The Company Is Also Developing Eb-002, Formerly Eb-373, A Next-Generation Synthetic Prodrug Of The Active Metabolite, Psilocin, Which Is Being Studied As A Treatment For Psychiatric Disorders.